Scientific Strategic Plan
The Enterprise's scientific strategic plan
for accelerating HIV vaccine research was published in the February 2005 issue of
Public Library of Science (PLoS) — Medicine.
The plan describes the major challenges facing the field and makes recommendations in six priority areas:
1
Vaccine Discovery
The immediate goal is to design candidate vaccines that cause the immune system to produce protective responses from both of its major arms — cellular immunity and neutralizing antibodies.
Read More
2
Laboratory Standardization
The laboratory assays that researchers use to assess immune response may not be comparable, severely hampering decisions about which candidates to pursue for further testing.
Read More
3
Product Development and Manufacturing
Once researchers have identified a vaccine design that they believe is promising, a critical phase of vaccine research is developing a manufacturing process that yields consistent batches over time.
Read More
4
Clinical Trials Capacity
Three phases of clinical trials in humans are required to fully test a vaccine candidate.
Read More
5
Regulatory Issues
National regulatory oversight of clinical trials is the cornerstone of safe and scientifically valid medical research.
Read More
6
Intellectual Property Issues
Researchers routinely seek patents and other intellectual property protections for their inventions.
Read More